{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:08:37Z","timestamp":1792796917362,"version":"4.5.0"},"reference-count":16,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/14740338.2025.2490841","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T11:15:57Z","timestamp":1744110957000},"page":"1785-1791","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2969-4769","authenticated-orcid":false,"given":"Michael B.","family":"Andrews","sequence":"first","affiliation":[{"name":"Virginia Commonwealth University","place":["Richmond"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-6285","authenticated-orcid":false,"given":"Douglas G.","family":"Adler","sequence":"additional","affiliation":[{"name":"Porter Adventist Hospital\/PEAK Gastroenterology","place":["Denver"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.08.010"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01116-z"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.922063"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X17718677"},{"issue":"7","key":"e_1_3_5_6_1","first-page":"438","article-title":"Eluxadoline (Viberzi): a mu-opioid receptor agonist for the treatment of irritable bowel syndrome with diarrhea","volume":"42","author":"Maltz F","year":"2017","unstructured":"Maltz F, Fidler B. Eluxadoline (Viberzi): a mu-opioid receptor agonist for the treatment of irritable bowel syndrome with diarrhea. P T. 2017;42(7):438\u2013442.","journal-title":"P T"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000327"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756284819897531"},{"key":"e_1_3_5_9_1","unstructured":"Butt I Kasmin FA. Alosetron In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. [Updated 2024 Jul 2]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553080\/"},{"key":"e_1_3_5_10_1","unstructured":"Questions and answers on FDA\u2019s adverse event reporting system (FAERS) [internet]. FDA; 2024 [cited 2024 Nov 2]. Available from: https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181577654"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14504"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004409"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.08.003"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00762.x"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0084-x"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X13491798"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2025.2490841","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14740338.2025.2490841","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2025.2490841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:23:32Z","timestamp":1788258212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2025.2490841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/14740338.2025.2490841"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2025.2490841","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}